Most Recent
Customers of mortgage lending and investment firm RMBL say they were “shocked” when the company’s chief financial officer allegedly called them to say “he hoped” they would opt out of an excessive fees class action that had been filed against the firm.
The applicants in a class action against Navra Group have dropped their case after group members settled their claims in a separate proceeding with the defunct financial planner's liquidators.
A judge overseeing a class action against engineering company UGL has agreed to extend a class closure order to give the parties a second chance to resolve the case in mediation, but not without expressing concerns that the order did not have the intended effect of encouraging settlement at the first sit-down.
The Queensland government has agreed to pay $190 million to resolve an historic class action on behalf of 10,000 Indigenous workers for unpaid wages spanning over 30 years.
A Federal Court judge has appointed a costs referee in a shareholder class action against two units of dairy co-op Murray Goulburn over a 2016 profit forecast revision which recently settled for $42 million.
The Australian Competition & Consumer Commission has commenced legal action against Samsung Electronics for allegedly making false, misleading and deceptive representations when marketing the water resistant capabilities of its Galaxy smartphones.
A judge overseeing competing consumer class actions against AMP over superannuation fees said he would be "reluctant" to hold a contest between the two cases, as the applicants in the rival proceedings tell the court they are in talks about possible consolidation.
A judge has released his reasons for consolidating two shareholder class actions against logistics company Brambles over opposition by the lead applicant in one of the competing cases, saying the interests of group members trumped those of the lawyers and funders in the case.
Sirtex Medical has reached a mid-trial agreement to resolve a shareholder class action that centred on the biotech company's sales forecasts of its radiation treatment.